CBO Blog

  • CBO and JCT have estimated the effects on revenues and spending of many of the President’s budgetary proposals. This report builds on an earlier one that focused on the President’s proposals for discretionary spending.

  • CBO discusses prescription drug prices and approaches aimed at reducing those prices. Some of the approaches would cap prices or limit their growth, and other approaches would promote price competition or affect the flow of information.

  • CBO examines changes in family wealth from 1989 to 2022 using a measure of wealth that includes projected Social Security benefits. Over that period, family wealth was unevenly distributed, and wealth inequality increased.

  • CBO provides information about the amount of damage that could be reduced through spending for flood adaptations—projects aimed at preventing damage from flooding.

  • CBO discusses the outlook for housing starts over the next 30 years—that is, the number of new single-family and multifamily housing units on which construction will be started—and describes the methodology behind its projections.

  • CBO examines ways in which the federal government and private entities share the risk involved in various federal credit programs, including those related to home mortgages, small businesses, and project financing.

  • CBO uses several measures of student loan repayment to describe borrowers’ outcomes from 2009 to 2019, before payments were suspended during the pandemic.

  • New policies implemented by the federal government affected transfers and taxes in 2021. The policies largely benefited lower- and middle-income households. But income inequality still increased, mainly because of realized capital gains.

  • Molly Dahl, CBO's Chief of Long-Term Analysis, testifies before the Senate Committee on the Budget.

  • CBO’s Director, Phillip Swagel, testifies before the House Committee on the Budget.